Contemporary insights into painful diabetic neuropathy and treatment with spinal cord stimulation

Current Pain and Headache Reports

Volumn 16, Issue 1, 2012, Pages 43-49

  McGreevy, Kai ^a   Williams, Kayode A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anesthetic techniques; Diabetes; Diabetic neuropathy; Pain management; Spinal cord stimulation

Indexed keywords

4 AMINOBUTYRIC ACID; ADVANCED GLYCATION END PRODUCT; CALCITONIN GENE RELATED PEPTIDE; DESIPRAMINE; DULOXETINE; GABAPENTIN; HYDROCODONE; MEXILETINE; MITOGEN ACTIVATED PROTEIN KINASE; MORPHINE; NARCOTIC ANALGESIC AGENT; NEUROTROPHIC FACTOR; NITRIC OXIDE; NORTRIPTYLINE; PARACETAMOL; POLYOL; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SODIUM CHANNEL; THIOCTIC ACID; TRICYCLIC ANTIDEPRESSANT AGENT; VANILLOID RECEPTOR 1; VENLAFAXINE; VOLTAGE GATED CALCIUM CHANNEL;

ALLODYNIA; ANTIDROMIC STIMULATION; CARDIOVASCULAR DISEASE; CHANNELOPATHY; CONSTIPATION; DIABETIC NEUROPATHY; DYSESTHESIA; ELECTROMYOGRAM; GATE CONTROL THEORY; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEFICIENCY; NERVE CONDUCTION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; ORTHOSTATIC HYPOTENSION; PAINFUL DIABETIC PERIPHERAL NEUROPATHY; PARESTHESIA; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; POLYNEUROPATHY; REVIEW; SEDATION; SENSORY NEUROPATHY; SEXUAL DYSFUNCTION; SIDE EFFECT; SPINAL CORD STIMULATION; XEROSTOMIA;

ANALGESICS, OPIOID; ANTIDEPRESSIVE AGENTS, TRICYCLIC; COST-BENEFIT ANALYSIS; DIABETIC NEUROPATHIES; ELECTRIC STIMULATION THERAPY; HUMANS; PAIN MEASUREMENT; SPINAL CORD;

EID: 84857624090     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-011-0230-2     Document Type: Review

References (41)

1. S Wild G Roglic A Green, et al. 2004 Global prevalence of diabetes estimates for the year 2000 and projections for 2030 Diabetes Care 27 1047 1053 15111519 10.2337/diacare.27.5.1047 (Pubitemid 38579764)
2. Y Zhao W Ye KS Boye, et al. 2009 Healthcare charges and utilization associated with diabetic neuropathy: impact of Type 1 diabetes and presence of other diabetes-related complications and comorbidities Diabet Med 26 61 69 19125762 10.1111/j.1464-5491.2008.02616.x 1:STN:280:DC%2BD1M%2FlsFehuw%3D%3D
3. • American Diabetes Association: Economic cost of diabetes in the U.S. in 2007. Diabetes Care 2008;31:596-615. This article provides a very comprehensive overview of the cost of care for diabetes and diabetes-related comorbidities throughout the entire continuum of the health care system.
4. C Daousi SJ Benbow A Woodward, et al. 2006 The natural history of chronic painful diabetic neuropathy in a community diabetes population Diabet Med 23 1021 1024 16922710 10.1111/j.1464-5491.2006.01904.x 1:STN:280: DC%2BD28vpvFSgug%3D%3D (Pubitemid 44257948)
5. AJ Boulton J Drury B Clarke, et al. 1982 Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy Diabetes Care 5 386 390 7151654 10.2337/diacare.5.4.386 1:STN:280:DyaL3s7gsVKrsQ%3D%3D (Pubitemid 12093554)
6. SO Oyibo YD Prasad NJ Jackson, et al. 2002 The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study Diabet Med 19 870 873 12358878 10.1046/j.1464-5491.2002.00801.x 1:STN:280:DC%2BD38vpslyjug%3D%3D (Pubitemid 35177190)
7. D Podwall C Gooch 2004 Diabetic neuropathy: clinical features, etiology and therapy Curr Neurol Neurosci Rep 4 55 61 14683630 10.1007/s11910-004-0013-9 (Pubitemid 38899053)
8. PJ Oates 2002 Polyol pathway and diabetic peripheral neuropathy Int Rev Neurobiol 50 325 366 12198816 10.1016/S0074-7742(02)50082-9 1:CAS:528: DC%2BD38XotFaqurc%3D
9. M Kihara Y Mitsui M Shioyama, et al. 2001 Effect of zenarestst, an aldose reductase inhibitor, on endoneurial blood flow in experimental diabetic neuropathy of rat Neurosci Lett 310 81 84 11585572 10.1016/S0304-3940(01)02052-3 1:CAS:528:DC%2BD3MXmsFels7k%3D (Pubitemid 32822809)
10. Krendal DA: Diabetic neuropathies. In Neuromuscular Function and Disease: Basic Clinical and Electrodiagnositc Aspects. Edited by Brown WE, Bolton CE, Aminoff MD. Philadelphia: WB Suanders; 2002:1061-80.
11. The Diabetes Control and Complications Trial Research Group 1995 The effect of intensive diabetic therapy on the development and progression of neuropathy Ann Intern Med 122 561 568
12. PJ Thomalley 2002 Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options Int Rev Neurobiol 50 37 50 10.1016/S0074-7742(02)50072-6
13. NE Cameron S Eaton MA Cotter, et al. 2001 Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy Diabetologia 44 1973 1988 11719828 10.1007/s001250100001 1:CAS:528:DC%2BD38XisFGmtg%3D%3D (Pubitemid 33124042)
14. KE Hall J Liu AA Sima, et al. 2001 Impaired inhibitory G-protein function contributes to increased calcium currents in rats with diabetic neuropathy J Neurophysiol 86 760 770 11495948 1:CAS:528:DC%2BD3MXmsVOnt70%3D (Pubitemid 32738565)
15. BS Shah MI Gonzales S Bramwell, et al. 2001 β3, a novel auxiliary subunit for the voltage gated sodium channel is upregulated in sensory neurones following streptozocin induced diabetic neuropathy in rat Neurosci Lett 309 1 4 11489532 10.1016/S0304-3940(01)01976-0 1:CAS:528:DC%2BD3MXlslGgtL4%3D (Pubitemid 32728245)
16. SP Novella SE Inzucchi JM Goldstein, et al. 2001 The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy Muscle Nerve 24 1229 1231 11494278 10.1002/mus.1137 1:STN:280:DC%2BD3Mvks1Omtg%3D%3D (Pubitemid 32762153)
17. CJ Summer S Sheth JW Griffith, et al. 2003 The spectrum of neuropathy in diabetes and glucose tolerance Neurology 60 108 111 (Pubitemid 36070653)
18. J Partanen L Niskansen J Lehtinen, et al. 1995 Natural history of peripheral neuropathy in patients with non-insulin dependent diabetes mellitus N Engl J Med 333 89 94 7777034 10.1056/NEJM199507133330203 1:STN:280: DyaK2M3psFyjtA%3D%3D
19. M Polydefkis P Hauer JW Griffin, et al. 2001 Skin biopsy as a tool to assess distal small fiber innervations in diabetic neuropathy Diabetes Technol Ther 3 23 28 11469706 10.1089/152091501750219994 1:STN:280: DC%2BD3MvhvFyqtA%3D%3D (Pubitemid 32405674)
20. • Kilpatrick ES, Rigby AS, Atkin SL: The Diabetic Control and Complications Trial: the gift that keeps giving. Nat Rev Endocrinol 2009;5:537-45. This thorough review of the background and data to date of the Diabetic Control and Complications Trial provides valuable data from a cohort studied for over a quarter of a century, with detailed information on relationship of glycemic control and the entire spectrum of diabetic complications.
21. RW Hurley MR Lesley MC Adams CM Brummett CL Wu 2008 Pregabalin as a treatment for painful diabetic peripheral neuropathy: a meta-analysis Reg Anesth Pain Med 33 389 394 18774507 1:CAS:528:DC%2BD1cXhtV2itr7I
22. • Ziegler D: Painful diabetic neuropathy: advantage of novel drugs over old drugs? Diabetes Care 2009;32 Suppl 2:S414-9. This is an excellent review of the pharmacological therapeutic options for the treatment of PDPN. Detailed information on the numbers needed to treat and harm allows for data-driven therapy for PDPN.
23. I Gilron JM Bailey D Tu, et al. 2005 Morphine, gabapentin, or their combination for neuropathic pain N Engl J Med 352 1324 1334 15800228 10.1056/NEJMoa042580 1:CAS:528:DC%2BD2MXislCjsbY%3D (Pubitemid 40411499)
24. D Ziegler H Nowak P Kempler, et al. 2004 Treatment of symptomatic diabetic polyneuropathy with the anti-oxidant α-lipoic acid: a meta-analysis Diabet Med 21 114 121 14984445 10.1111/j.1464-5491.2004.01109.x 1:CAS:528:DC%2BD2cXhvFSgtrs%3D (Pubitemid 38221809)
25. D Zeigler A Ametov A Barinov, et al. 2006 Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial Diabetes Care 29 2365 2370 10.2337/dc06-1216 (Pubitemid 44912237)
26. R Melzack PD Wall 1965 Pain mechanisms: a new theory Science 150 971 979 5320816 10.1126/science.150.3699.971 1:STN:280:DyaF28%2FktFKjtg%3D%3D
27. C El-Khoury M Hawwa M Baliki, et al. 2002 Attenuation of neuropathic pain by segmental and supraspinal activation of the dorsal column system in awake rats Neuroscience 112 541 553 12074897 10.1016/S0306-4522(02)00111-2 1:CAS:528:DC%2BD38XksFyqsb4%3D (Pubitemid 34634149)
28. • Wu M, Linderoth B, Foreman RD: Putative mechanism behind effects of spinal cord stimulation on vascular diseases: a review of experimental studies. Auton Neurosci 2008;138:9-23. This is an excellent article to read for a clear understanding of the effects of SCS on the CVS through the sympathetic system. Diagrams and layout allow for a clear understanding of the science.
29. JE Croom RD Foreman MJ Chandler, et al. 1997 Cutaneous vasodilatation during dorsal column stimulation is mediated by dorsal roots and CGRP Am J Physiol 272 H950 H957 9124459 1:CAS:528:DyaK2sXhvVajtr8%3D
30. HM Goksel O Karadag U Turaclar, et al. 2001 Nitric oxide synthetase inhibition attenuates vasoactive response to spinal cord stimulation in an experimental model Acta Neurochir (Wien) 143 383 390 10.1007/s007010170094 1:STN:280:DC%2BD38%2Fhs12jsA%3D%3D (Pubitemid 32463979)
31. M Wu N Komori C Qin, et al. 2006 Sensory fibers containing vanilliod receptor-1 (VR-1) mediate spinal cord stimulation-induced vasodilatation Brain Res 1107 177 184 16836986 10.1016/j.brainres.2006.05.087 1:CAS:528: DC%2BD28XotlWksbo%3D (Pubitemid 44205116)
32. M Wu N Komori C Qin, et al. 2008 Extracellular signal regulated kinase (ERK) and protein kinase B (AKT) pathways involved in spinal cord stimulation (SCS)-induced vasodilatation Brain Res 207 73 83 10.1016/j.brainres.2007.12.072
33. • Prager JP: What does the mechanism of spinal cord stimulation tell us about complex regional pain syndrome? Pain Med 2010;11:1278-83. This is an excellent review of how the mechanism of action of SCS informs the understanding of the neuropathic pain conditions, complex regional pain syndrome in particular.
34. CO Stiller JG Cui WT O'Connor, et al. 1996 Release of gamma-aminobutyric acid in the dorsal horn and the suppression of tactile allodynia by spinal cord stimulation in mononeuropathic rats Neurosurgery 39 367 374 8832675 10.1097/00006123-199608000-00026 1:STN:280:DyaK28vivFGktg%3D%3D (Pubitemid 26251559)
35. G Schectmann Z Song C Ulitenius, et al. 2008 Cholinergic mechanisms involved in pain relieving effect of spinal cord stimulation in a model of neuropathy Pain 139 136 145 10.1016/j.pain.2008.03.023
36. B Linderoth CO Stiller L Gunasekera, et al. 1994 Gamma-aminobutyric acid is released in the dorsal horn by electrical spinal cord stimulation: an in vivo microdialysis study in the rat Neurosurgery 34 484 488 8190224 10.1227/00006123-199403000-00014 1:STN:280:DyaK2c3kslGrsw%3D%3D
37. S Tesfaye J Watt SJ Benbow, et al. 1996 Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy Lancet 348 1698 1701 8973433 10.1016/S0140-6736(96)02467-1 1:STN:280:DyaK2s7ivVyqsQ%3D%3D (Pubitemid 27007534)
38. C Daousi SJ Benbow IA MacFarlane 2005 Electrical stimulation in the long-term treatment of chronic painful diabetic neuropathy Diabet Med 22 393 8 15787662 10.1111/j.1464-5491.2004.01410.x 1:STN:280:DC%2BD2M7lsFSrug%3D%3D (Pubitemid 40516236)
39. CC de Vos V Rajan W Steenbergen, et al. 2009 Effect and safety of spinal cord stimulation for the treatment of chronic pain caused by diabetic neuropathy J Diabetes Complications 23 40 5 18413161 10.1016/j.jdiacomp.2007.08.002
40. L Kapural S Hayek M Stanton-Hicks, et al. 2004 Decreased insulin requirements with spinal cord stimulation in a patient with diabetes Anesth Analg 98 745 6 14980930 10.1213/01.ANE.0000102674.41527.1E (Pubitemid 38252669)
41. JY Jeon CB Weiss RD Steadward, et al. 2002 Improved glucose tolerance and insulin sensitivity after electrical stimulation-assisted cycling in people with spinal cord injury Spinal Cord 40 110 7 11859437 10.1038/sj.sc.3101260 1:STN:280:DC%2BD387ktF2gsA%3D%3D (Pubitemid 34188276)